Graphical abstract Highlights • The pandemic of COVID-19 remains to affect the whole world. • Current remedies for COVID-19 is not satisfactory/available. • The therapeutic efficacy of Natural Compounds is well explored in various viral infections. • Natural Compounds could be explored as target specific therapeutic agents against COVID-19 infection. The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) recently caused a pandemic outbreak called coronavirus disease 2019 (COVID-19). This disease has initially been reported in China and also now it is expeditiously spreading around the globe directly among individuals through coughing and sneezing. Since it is a newly emerging viral disease and obviously there is a lack of anti-SARS-CoV-2 therapeutic agents, it is urgently required to develop an effective anti-SARS-CoV-2-agent.Through recent advancements in computational biology and biological assays, several natural compounds and their derivatives have been reported to confirm their target specific antiviral potential against Middle East respiratory syndrome coronavirus (MERS-CoV) or Severe Acute Respiratory Syndrome(SARS-CoV).These targets including an important host cell receptor, i.e., angiotensin-converting enzyme ACE2 and several viral proteins e.g. spike glycoprotein (S) containing S1 and S2 domains, SARS CoV Chymotrypsin-like cysteine protease (3CL pro ), papain-like cysteine protease (PL pro ), helicases and RNA-dependent RNA polymerase (RdRp). Due to physical, chemical, and some genetic similarities of SARS CoV-2 with SARS−COV and MERS−COV, repurposing various anti-SARS−COV or anti-MERS−COV natural therapeutic agents could be helpful for the development of anti−COVID-19 herbal medicine. Here we have summarized various drug targets in SARS−COV and MERS−COV using several natural products and their derivatives, which could guide researchers to design and develop a safe and cost-effective anti-SARS−COV-2 drugs.
【저자키워드】 SARS-CoV-2, SARS, MERS, herbal medicines, natural compounds, 【초록키워드】 COVID-19, SARS CoV-2, coronavirus disease, ACE2, pandemic, Antiviral, Genetic, spike glycoprotein, drugs, 3CL pro, anti-SARS-CoV-2, MERS-CoV, viral infections, Helicase, China, COVID-19 infection, outbreak, drug target, RdRP, RNA-dependent RNA polymerase, target, therapeutic agent, viral disease, therapeutic agents, respiratory, disease, Angiotensin-converting enzyme, Coronavirus-2, similarity, Safe, Middle East, natural, acute respiratory syndrome, Viral protein, Abstract, domains, SARS CoV, individual, Compound, cysteine protease, therapeutic efficacy, host cell receptor, coughing, respiratory syndrome coronavirus, derivative, pandemic of COVID-19, derivatives, researcher, Affect, physical, effective, current, S1 and S2, lack, develop, caused, globe, reported, assays, required, 【제목키워드】 Drug discovery, SARS-COV-2 infection, Compound, approach, current,